Abstract 1291
Case Summary
Patient. 46 years old. Female. Has been ill since 6 month. Has not another diseases. Family history free. Endoscopy has shown submucosal lesion with infiltrative tumor on the antrum. The size of the submocosal lesion was 2,5 x 3.0 cm. The overlying mucosa in the middle of the submucosal lesion was ulterated. The biopsies have taken from both sites. Histologic examination of infiltrative region revealed adenocarcinoma G3. Biopsies of submucosal lesion was negative. The physical examination and routine laboratory tests upon admission were unremarkable. The histopathologic examination after operation has revealed an adenocarcinoma G3 of stomach, that has been infiltrating into the muscular layer. In microscopic examination of submucosal lesion have been found a spindle cells neoplasm located in muscularis propria extending up to serosa. In immunohistochemical studing for desmin and CD-117 which confermed the diagnosis of gastrointestinal stromal tumor. The mitotic count was 6/50 HPF. Also, in the side with ulceration of GIST have been found cells of adenocarcinoma. The patient has been undergone distal subtotal gastrectomy and Billroth-II gastrojejunal anastomosis with D2 lymphadenectomy. The patient has not received imatinibas adjuvant therapy for the GIST, according to the international guidelines for GISTs risk stratification. The patient underwent regular clinical and radiological follow-up every 4 months after discharge. No evidence of tumor recurrence was found after 12 months of follow-up.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
905 - Dose distribution in coronary arteries in left-sided breast cancer treated with Radiotherapy
Presenter: Umesh Velu
Session: Poster display - Cocktail
Resources:
Abstract
1060 - Metabolic Syndrome in Luminal-Type Non-Metastatic Breast Cancer during Hormonal Treatment Does it really have impact on prognosis?
Presenter: Kartika Taroeno-Hariadi
Session: Poster display - Cocktail
Resources:
Abstract
1148 - High Eosinophils Lymphocyte Ratio (ELR) Related With Subtype of Breast Cancer in Sanglah General Hospital, Bali
Presenter: Anak Agung Lestari
Session: Poster display - Cocktail
Resources:
Abstract
400 - Ribociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
Presenter: Norikazu Masuda
Session: Poster display - Cocktail
Resources:
Abstract
801 - Osteopontin Level and Promoter Polymorphism is Associated with Aggressiveness in Breast Cancer
Presenter: Mohamed Elbaiomy
Session: Poster display - Cocktail
Resources:
Abstract
1014 - Global Clinical Trials Validating Bioequivalence with China-Manufactured Trastuzumab Biosimilar, HLX02, and Herceptin®
Presenter: Quanying Zhang
Session: Poster display - Cocktail
Resources:
Abstract
1138 - Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s
Presenter: Yunjie He
Session: Poster display - Cocktail
Resources:
Abstract
145 - Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India.
Presenter: Abhishek Anand
Session: Poster display - Cocktail
Resources:
Abstract
804 - Meta-analysis of four Phase 3 RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as 1st Line Endocrine Therapy for HR+ Advanced Breast Cancer
Presenter: John Robertson
Session: Poster display - Cocktail
Resources:
Abstract
1154 - Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients
Presenter: Sung Soo Kang
Session: Poster display - Cocktail
Resources:
Abstract